Copyright © 2018 Claristock. All Right Reserved
Total Mark
85
Above 70 is preferred
Stock Analysis
| Growth Potential | 62 | |
|---|---|---|
| Profitability | 97 | |
| Financial Strength | 92 | |
| Result 2019 | 75 | |
| Result 2018 | 33 | |
| Result 2020 | 100 |
Growth Estimate
| 21 Estimate | 22 Estimate | |
|---|---|---|
| Revenue Growth (%) | 7.4 | 26.9 |
| EPS Growth (%) | -47.8 | 86 |
| ROE (%) | 16.5 | 26.5 |
| P/E (times) | ... | ... |
Market Analysis
| Market Sentiment | ||
|---|---|---|
| Relative Valuation | ||
| Being a Value Stock | ||
| Absolute Valuation |
For more detailed information about Neurocrine Biosciences, Inc., please go to Yahoo Finance